Navigation Links
Pharma IQ's Compound Management Survey Report
Date:3/14/2012

at the Drosophila RNAi Screening (Stephanie Mohr PhD, Director of the Drosophila RNAi Screening Center, Harvard Medical School)
  • Sample management workflows and supporting software (Janet Diratsaoglu, Principal Scientist, Roche)
  • Building a cDNA and RNAi library management system (Karen Billeci Scientific Manager, Assay & Automation Technology Group Genentech)
  • Library strategies: A model for academic/industrial collaboration in drug discovery: the rare paediatric brain tumour campaign at St. Jude Children's Research Hospital (Anang Shelat, Director, Lead Discovery Informatics and Compound Management, Department of Chemical Biology and Therapeutics
    St. Jude Children's Research Hospital)
  • To access the full survey report or to find out more about  Compound and Sample Management   please visit http://www.compoundmanagercom/NEWS, emailenquire@iqpc.co.uk or call +44(0)20-7036-1300

    Media contact: Joanna, +44(0)20-7368-9421, joanna.checinska@iqpc.co.uk - Please contact for more information or images.

    Press are invited to attend this important industry forum, if you would like to a complimentary press pass please email Joanna Checinska (jaonna.checinska@iqpc.co.uk)



    '/>"/>
    SOURCE Pharma IQ
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2

    Related biology technology :

    1. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2011 Financial Results on March 12, 2012
    2. PharmAthene to Present at the 24th Annual ROTH Conference on Monday, March 12, 2012
    3. Enox Biopharma, Inc. Will Present at IN360 Investment in Innovation Conference
    4. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results
    5. PDL BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results
    6. Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
    7. Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
    8. Swedish Bactiguard to Enter Into an Exclusive Distribution Agreement With Cadila Pharmaceuticals
    9. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2011 Financial Results on Wednesday, March 7, 2012
    10. BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals
    11. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/22/2014)... HONG KONG , Oct. 22, 2014 ... enterprise, announced today that rare disease expert John ... president, research. Dr. McKew brings more than two decades ... at the National Institutes of Health, Wyeth Research and ... McKew will lead aTyr,s efforts to expand and translate ...
    (Date:10/20/2014)... 2014 Asterias Biotherapeutics, Inc. (NYSE MKT: ... a Notice of Grant Award (NGA) with the ... 1, 2014.  The NGA provides for the immediate ... of additional grant funds pursuant to the previously ... development of Asterias, product, AST-OPC1. The grant provides ...
    (Date:10/20/2014)... 20, 2014 PureTech , a science ... healthcare problems, announced today the closing of a ... from Invesco Perpetual, a $120 Billion group of ... PureTech,s existing pipeline forward and to advance new ... scientific creativity to really go for the big ...
    (Date:10/19/2014)... (PRWEB) October 19, 2014 The Latin ... the market in Latin America with analysis and forecast ... in 2013, and is expected to reach $2,366.8 million ... to 2018. , Browse through the TOC of the ... idea of the in-depth analysis provided. It also provides ...
    Breaking Biology Technology:aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 2The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 3
    ... Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the ... ) focused on bringing the life saving potential ... today that Matthew Schissler, founder and CEO, in an ... is very close to becoming cash flow positive.The complete ...
    ... Feb. 5 Micromet, Inc. (Nasdaq: MITI ), today announced ... BIO CEO and Investor Conference at the Waldorf-Astoria in New York City ... be available on the company,s website at www.micromet-inc.com ., ... Date: Tuesday, February 10, 2009, ...
    ... Nutrition 21, Inc. (Nasdaq: NXXI ), ... Iceland Health(R), Chromax(R) and Diabetes Essentials(R) brands that help ... memory and reduce chronic joint pain, today announced financial ... of fiscal year 2009.For the quarter the Company reported ...
    Cached Biology Technology:In Analyst Interview, Cord Blood America Says Stem Cells Now Front and Center for Researchers and Investors 2Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 2Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 3Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 4Nutrition 21 Announces Second Consecutive Profitable Quarter in Q2 Fiscal 2009 2Nutrition 21 Announces Second Consecutive Profitable Quarter in Q2 Fiscal 2009 3Nutrition 21 Announces Second Consecutive Profitable Quarter in Q2 Fiscal 2009 4Nutrition 21 Announces Second Consecutive Profitable Quarter in Q2 Fiscal 2009 5Nutrition 21 Announces Second Consecutive Profitable Quarter in Q2 Fiscal 2009 6Nutrition 21 Announces Second Consecutive Profitable Quarter in Q2 Fiscal 2009 7
    (Date:10/16/2014)... monocultures can be cultivated efficiently, they are anything ... caused by monoculture cultivation is becoming increasingly evident. ... crop form and are regarded as the sole ... – quite wrongfully, finds Bernhard Schmid, an ecology ... a novel form of agriculture and forestry. After ...
    (Date:10/15/2014)... pandemic risk from strains of influenza virus increases with ... to become complacent that the most substantial threats have ... Influenza pandemics arise when a new virus strain – ... – spreads in the human population. There have been ... worst of which – the 1918 Spanish Flu – ...
    (Date:10/15/2014)... NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... growing mobile commerce market releases photos and video of the recent ... October 13 th . Gino Pereira , ... angel investor Mr. Chad A. Verdi rang the bell.  ... his investors and employees "for their work and dedication in bringing ...
    Breaking Biology News(10 mins):Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3
    ... developed a new method for delivering molecules into single, ... The technique could find applications in drug delivery, cell ... a technique used to deliver molecules into cells through ... by exposing them to electric pulses is an ...
    ... uphill battle? Try staying fit in space, where living quarters ... That,s the challenge a group of Michigan State University researchers ... NASA. Their goal is to keep astronauts motivated to exercise ... best exercise regimen there is, but if you can,t get ...
    ... Philips Electronics (NYSE: PHG, AEX: PHIA) today announced that CX50 ... Live 3D TEE, now offers 2-D Intracardiac Echo (ICE) capability. ... will be shown in Paris at ... Cardiovascular Inventions (EAPCI), May 21-24. Since its launch ...
    Cached Biology News:Single-cell transfection tool enables added control for biological studies 2Fueling fitness on the final frontier 2Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2
    Best pricing for 100mg-1.0g scales. Phosphopeptides are our specialty....
    ... 2D is an automated, two-dimensional fractionation system ... Part of Beckman Coulters ProteomeLab family ... in just hours. The system effectively ... cell lysates, addressing a key challenge in ...
    ... The Rapid-Screen cDNA Library Panels were designed ... three sets of PCRs to identify the ... is performed in a 96-well "Master Plate," ... 5,000 clones. Having identified the positive well(s) ...
    ... HORIBA Jobin Yvons Protein 295 ex ... a protein sample in only a few ... the amino acids tyrosine and tryptophan, the ... powerful NanoLED-17, a pulsed diode emitting 295 ...
    Biology Products: